Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Pacific Biosciences of California, Inc. on June 13, 2012. The filing details the outcomes of shareholder votes regarding director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events rather than financial performance.
Material Changes
No material financial changes are reported in this document. The primary events are the successful election of Class II directors and the ratification of the accounting firm.
Guidance, Outlook, and Management Commentary
The filing contains no guidance, outlook, or management commentary regarding future operations. It confirms that Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2012.
Key Facts for Investor Verification
- Three Class II directors were elected: Michael Hunkapiller, Randy Livingston, and Marshall Mohr.
- Michael Hunkapiller received the highest "For" vote count (36,573,095), while Randy Livingston received the lowest (35,486,363).
- Broker non-votes totaled 7,867,618 for all director elections.
- The ratification of Ernst & Young LLP passed with 44,558,637 votes "For" and only 108,135 votes "Against."
- No financial data is included in this specific filing; investors should refer to the most recent 10-K or 10-Q for financial metrics.